Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects.
Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects.
复制标题
DOI:
10.1016/j.ijcha.2022.101032
复制
发表时间:
2022-06
影响因子:
2.9
通讯作者:
Toyoda, Shigeru
中科院分区:
文献类型:
--
作者:
Fukuda, Taira;Nakajima, Toshiaki;Yazawa, Hiroko;Hirose, Suguru;Yokomachi, Jun;Kato, Takashi;Nishikawa, Riichi;Koshiji, Nobuo;Tokura, Michiaki;Nasuno, Takahisa;Nishino, Setsu;Obi, Syotaro;Shibasaki, Ikuko;Kanaya, Tomoaki;Nakamura, Fumitaka;Fukuda, Hirotsugu;Abe, Shichiro;Sakuma, Masashi;Toyoda, Shigeru
Sarcopenia is closely associated with postoperative prognosis in patients undergoing cardiovascular surgery. Growth differentiation factor (GDF)-15 is involved in the pathogenesis of cardiovascular disease. We examined the relationship between the serum GDF-15 concentration and muscle function in patients receiving aortic valve replacement and healthy elderly subjects. Forty-three female patients undergoing aortic valve surgery (79.9 ± 6.4 years; transcatheter aortic valve replacement [TAVR] n = 19, conventional surgical aortic valve replacement [SAVR] n = 24) and 64 healthy elderly female subjects (75.9 ± 6.1 years) were included. Walking speed, grip strength, and skeletal muscle mass index (SMI) by a multifrequency bioelectrical impedance analyzer were measured to determine the presence of sarcopenia. Preoperative serum GDF-15 concentration was measured by enzyme-linked immunosorbent assay. The GDF-15 level was higher in patients receiving aortic valve replacement than in healthy elderly subjects (aortic valve replacement: 1624 ± 1186 pg/mL vs. healthy: 955 ± 368 pg/mL, p < 0.001). Multivariate linear regression analysis showed that the serum GDF-15 level determined grip strength independently of the high-sensitivity C-reactive protein level and eGFR, even after adjusting for age (β = -0.318, p = 0.025). Sarcopenia was found in 12.5% of healthy elderly subjects, 83.3% of patients with TAVR, and 64.3% of patients with SAVR. The GDF-15 concentration that defined sarcopenia was 1109 pg/mL in subjects including patients receiving aortic valve replacement. The preoperative serum GDF-15 concentration, which was higher in female patients receiving aortic valve replacement than in healthy elderly subjects, may be a serum marker of sarcopenia.
登录
查看更多内容
DOI:
10.1016/j.ijcha.2020.100651
发表时间:
2020-12
期刊:
International journal of cardiology. Heart & vasculature
影响因子:
--
作者:
Yazawa H;Fukuda T;Kaneda H;Waku R;Sakuma M;Matsumoto A;Toyoda S;Abe S;Nakamura F;Inoue T;Nakajima T
通讯作者:
Nakajima T
影响因子:
39.3
作者:
Fuelster, Susann;Tacke, Matthias;von Haehling, Stephan
通讯作者:
von Haehling, Stephan
影响因子:
37.8
作者:
Shimura, Tetsuro;Yamamoto, Masanori;Hayashida, Kentaro
通讯作者:
Hayashida, Kentaro
影响因子:
158.5
作者:
Mack, M. J.;Leon, M. B.;Smith, C. R.
通讯作者:
Smith, C. R.
影响因子:
10
作者:
Garfield, Benjamin E.;Crosby, Alexi;Kemp, Paul R.
通讯作者:
Kemp, Paul R.